April 2026– date –
-
From Beginner to Expert | Bispecific Antibody Drug Series B5: How Should We Think About Clinical Development Strategy and Indication Expansion?
Bispecific antibody drugs are a modality in which theoretical appeal alone is not enough; where and how clinical development begins is critically important. As we have seen from A1 through A5 and B1 through B4, this field is shaped by st... -
From Beginner to Expert | Bispecific Antibody Drug Series A5: Where Do Bispecific Antibody Drugs Sit Within the Overall Landscape of Cancer Therapy?
Bispecific antibody drugs have gained a strong presence within cancer therapy over the past several years. However, to truly understand this field, it is not enough to look at bispecific antibody drugs in isolation. What matters is to pl... -
From Beginner to Expert | Bispecific Antibody Drug Series B4: How Should We Think About Toxicity, PK/PD, and Development Bottlenecks?
Bispecific antibody drugs are a modality that often looks highly attractive in theory. Because they can handle two targets within a single molecule, they can aim for pharmacological effects that are difficult to achieve with single-targe... -
From Beginner to Expert | Bispecific Antibody Drug Series A4: Why Do Adverse Effects Occur? Understanding the Balance Between Efficacy and Safety
Bispecific antibody drugs are a modality with enormous promise in cancer therapy. As we have seen from A1 through B3, the strength of this field lies in the ability of a single molecule to engage two targets or conditions and achieve pha... -
From Beginner to Expert | Bispecific Antibody Drug Series B3: How Differences in Modality Shape Pharmacological Properties
When we look at bispecific antibody drugs, it becomes clear that even though they are grouped under the same label, they can behave very differently as actual medicines. One molecule may show very strong cell-bridging activity while stru... -
From Beginner to Expert | Bispecific Antibody Drug Series A3: What Types Are There? Classification and the Overall Landscape of Bispecific Antibody Drugs
Bispecific antibody drugs are often discussed as if they were a single technological field. In reality, however, their internal diversity is substantial. As we saw in A1, the essence of bispecific antibody drugs is to connect two targets... -
From Beginner to Expert | Bispecific Antibody Drug Series B2: What Determines Target Design and the Optimization of Mechanism of Action?
When people think about the design of bispecific antibody drugs, they often focus first on which targets should be combined. That is natural, because the value of bispecific antibody drugs arises from handling two targets at the same tim... -
From Beginner to Expert | Bispecific Antibody Drug Series A2: How Do Bispecific Antibody Drugs Work? A Clear Guide to Their Mechanisms of Action
One of the reasons bispecific antibody drugs attract so much attention is that they can bind two targets within a single molecule. However, as we saw in A1 and B1, what truly matters is not simply the fact that they can bind two things. ... -
From Beginner to Expert | Bispecific Antibody Drug Series B1: Comparing Structural Designs and Their Impact on Therapeutic Effects
One of the first major hurdles in understanding bispecific antibody drugs is recognizing that the single term “bispecific antibody drugs” actually includes fundamentally different molecular design concepts. In A1, we described bispecific...
1